Fields questions regarding gain-of-function. Director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, who has overseen much of the pandemic response, testified in a…
Read MoreCoronavirus
Committee Admits Difficulty in Tracking Pandemic Money
Report says, “It’s even harder” to know what the funds were used for. When Congress passed the Coronavirus Aid, Relief, and Economic Stability Act in 2020, they also established…
Read More
At-Home COVID-19 Tests to Become More Accessible
President’s administration sets aside $70 million for new test development. On Monday, the White House announced that it would begin a cross-department initiative to make over-the-counter at-home COVID-19…
Read More
White House Announces Plan to Vaccinate Children
28 million children between 5 and 11 years old could be eligible if the vaccine is approved next month. The White House announced on Wednesday that it is…
Read More
FDA Studies Moderna Shot’s Side Effects in Youth
Approval paused for evaluation of myocarditis in males under 30. The Food and Drug Administration is reportedly delaying approval of Moderna’s COVID-19 authorization for teens to study the…
Read More
FDA Panel Endorses J&J Booster Shot
Advisors unanimously approve. Johnson & Johnson’s vaccine was the only approved COVID-19 vaccine that only technically required a single dose to be effective. After a number of additional…
Read More
Pfizer Seeks FDA Approval for Shots for Children 5 to 11
28 million children could soon be eligible for vaccination. On Thursday, Pfizer formally requested approval from the Food and Drug Administration (FDA) to begin administering COVID-19 vaccines to…
Read More
J&J Seeks FDA Approval for Booster Shots
Claims second shot increases protection 13 percentage points. On Tuesday, Johnson & Johnson requested the Food and Drug Administration (FDA) to approve additional use of its COVID-19 vaccine…
Read More
School Board Association Asks for Federal Investigation
CRT curriculum and mask mandates draw protesters to board meetings nationwide. Last week, the National School Boards Association (NSBA) requested federal assistance and an investigation as parents have…
Read More
New Pill “Gamechanger” Against COVID
Cuts hospitalizations and deaths in half. Pharmaceutical company Merck says new data on Molnupiravir shows a reduced risk of hospitalization or death by up to 50 percent in clinical trials. …
Read More